These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24588986)

  • 1. Applying principles from behavioral economics to promote long-acting reversible contraceptive (LARC) methods.
    Stevens J; Berlan ED
    Perspect Sex Reprod Health; 2014 Sep; 46(3):165-70. PubMed ID: 24588986
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Acting Reversible Contraceptives and Adolescents: Assessing Benefits and Overcoming Barriers.
    McKnight ER; Berlan ED
    Adolesc Med State Art Rev; 2014 Aug; 25(2):347-59. PubMed ID: 27132318
    [No Abstract]   [Full Text] [Related]  

  • 3. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
    Secura GM; Allsworth JE; Madden T; Mullersman JL; Peipert JF
    Am J Obstet Gynecol; 2010 Aug; 203(2):115.e1-7. PubMed ID: 20541171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing LARC utilization: any woman, any place, any time.
    Hathaway M; Torres L; Vollett-Krech J; Wohltjen H
    Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
    Ricketts S; Klingler G; Schwalberg R
    Perspect Sex Reprod Health; 2014 Sep; 46(3):125-32. PubMed ID: 24961366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women or LARC first? Reproductive autonomy and the promotion of long-acting reversible contraceptive methods.
    Gomez AM; Fuentes L; Allina A
    Perspect Sex Reprod Health; 2014 Sep; 46(3):171-5. PubMed ID: 24861029
    [No Abstract]   [Full Text] [Related]  

  • 8. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
    Pritt NM; Norris AH; Berlan ED
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.
    Blumenthal PD; Voedisch A; Gemzell-Danielsson K
    Hum Reprod Update; 2011; 17(1):121-37. PubMed ID: 20634208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of long-acting reversible contraception users in Europe.
    Haimovich S
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):187-95. PubMed ID: 19565416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usage of Long Acting Reversible Contraceptive Methods (LARC) in couples attending for vasectomy counselling.
    Moses S; Oloto E
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):243-7. PubMed ID: 18609343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advocating for immediate postpartum LARC: increasing access, improving outcomes, and decreasing cost.
    Rodriguez MI; Evans M; Espey E
    Contraception; 2014 Nov; 90(5):468-71. PubMed ID: 25107639
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional variation in postabortion initiation of long-acting reversible contraception in New Zealand.
    Rose SB; Garrett SM
    Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):315-22. PubMed ID: 27060549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing the importance of long-acting contraception.
    Karpilow QC; Thomas AT
    Am J Obstet Gynecol; 2017 Feb; 216(2):148.e1-148.e14. PubMed ID: 27773713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries.
    Eeckhaut MC; Sweeney MM; Gipson JD
    Perspect Sex Reprod Health; 2014 Sep; 46(3):149-55. PubMed ID: 25040454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global fee prohibits postpartum provision of the most effective reversible contraceptives.
    Aiken AR; Creinin MD; Kaunitz AM; Nelson AL; Trussell J
    Contraception; 2014 Nov; 90(5):466-7. PubMed ID: 25212061
    [No Abstract]   [Full Text] [Related]  

  • 17. Using ARC to avoid unplanned pregnancy.
    Hearton L
    Nurs Times; 2012 Feb 21-27; 108(8):22, 24. PubMed ID: 22458082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating Long-acting Reversible Contraception Into Primary Care: A Training and Practice Innovation.
    Pace LE; Dolan BM; Tishler LW; Gooding HC; Bartz D
    Womens Health Issues; 2016; 26(2):131-4. PubMed ID: 26542381
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of a theory-based video on initiation of long-acting reversible contraception after abortion.
    Davidson AS; Whitaker AK; Martins SL; Hill B; Kuhn C; Hagbom-Ma C; Gilliam M
    Am J Obstet Gynecol; 2015 Mar; 212(3):310.e1-7. PubMed ID: 25265403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal and intrauterine contraception for women aged 40 years and older.
    Cwiak C; Allen R; Kaunitz AM
    Womens Health (Lond); 2013 Sep; 9(5):421-4. PubMed ID: 24007246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.